Medical Device News Magazine

Friday, March 31, 2023

Global Paediatric Interventional Cardiology Market Analysis to 2029

Featuring Medtronic, NeMED, GE Healthcare and Boston Scientific Among Others

The “Paediatric Interventional Cardiology Market Analysis by Device Type and by Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.

The paediatric interventional cardiology market size is estimated to be USD 1,581.3 million in 2021 and is expected to witness a CAGR of 11.18% during the forecast period 2022-2029.

Companies Mentioned:

  • St. Jude Medical Inc. (U.S.)
  • Medtronic Inc. (U.S.)
  • W.L. Gore & Associates Inc. (U.S.)
  • Edwards Lifesciences Corp (U.S.)
  • NuMED Inc. (U.S.)
  • Cordis Corporation (U.S.)
  • GE Healthcare (U.K.)
  • Siemens Healthcare (Germany)
  • Boston Scientific (U.S.)
  • Abbott Vascular (U.S.)

The increased rates of congenital heart disease and FDA initiatives to streamline the regulatory process, technical advances, which have resulted in the introduction of new and improved products is expected to drive the market.

However, changing stringency of regulatory procedures and presence of complex regulatory procedures is expected to restrain the market growth.

By Device Type

Based on device type, the market is segregated into transcatheter heart valves and congenital heart defect closure devices. In 2021, the congenital heart defect closure devices segment accounted for the highest revenue share due to a rising understanding of the importance of paediatric interventional cardiology devices and rising instances of congenital impairments.

Regional Markets

In 2021, Asia Pacific region accounted for the highest revenue in the paediatric interventional cardiology market and is expected to maintain its dominance during the forecast period. The increase in government funding for developing paediatric care facilities, and investments by prominent players in the APAC region. are all contributing to the market expansion.

Segmentation: Paediatric Interventional Cardiology Market Report 2021-2029

By Device Type (Revenue, USD Million)

  • Transcatheter Heart Valves
  • Congenital Heart Defect Closure Devices

By Region (Revenue, USD Million)

North America

  • U.S
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

For more information about this report visit https://www.researchandmarkets.com/r/an873x

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

U.S. Department of Defense Awards Theradaptive $4 Million Contract for Its OsteoAdapt Regenerative Therapeutic Program

The funds from the DOD contract will enable Theradaptive to continue its work to meet regulatory requirements and scale up Good Manufacturing Practices-compliant manufacturing of the OsteoAdapt product in preparation for clinical studies.

Macrolux Completes Nearly CNY100 million Series A Round: Funding Led by Legend Capital

Legend Capital has long been paying attention to the investment in the field of medical devices and diagnostics with a focus on three major themes: first, major diseases, especially the unmet clinical needs of chronic diseases; second, the first and uniqueness in technology, which enables a company to become or have the potential to become a leading player in subdivided industries; the third is the "device +" investment opportunities brought by the integration of medical devices and interdisciplinary technologies such as AI, IoT and Big Data.

Previa Medical Raises €2.1 Mil for AI Solution to Prevent Sepsis

Sepsis is one of the leading causes of hospital deaths worldwide, with a 30-day mortality rate of 20 to 30%. SEPSI-SCORE therefore provides a much-needed solution to a major global public health issue.
Subscribe to Medical Device News Magazine

By using this website you agree to accept Medical Device News Magazine Privacy Policy